|View printer-friendly version|
Array BioPharma to Present at Leerink Swann Conference
BOULDER, Colo.--(BUSINESS WIRE)--May 5, 2008--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Leerink Swann Conquering Cancer with Novel Therapeutics: Roundtable Conference on May 9 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: Leerink Swann Conquering Cancer with Novel Therapeutics:
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Friday, May 9, 2008
Time: 9:20 a.m. Eastern Time
Location: The Grand Hyatt New York, New York City
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory diseases and pain. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Array BioPharma Inc.
SOURCE: Array BioPharma Inc.